---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-039525"
form_type: "8-K"
ticker: "RNXT"
cik: "0001574094"
company_name: "RenovoRx, Inc."
filed_at: "2023-11-06T23:59:59+00:00"
generated_at: "2026-06-08T20:40:19.051297+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# RenovoRx gets Nasdaq extension to Feb 19, 2024 for $2.5M equity compliance

## Summary
- Nasdaq granted extension to February 19, 2024 to meet $2.5M stockholders' equity requirement (Rule 5550(b)(2)).
- Company must evidence full compliance by deadline; failure triggers delist determination.
- Delist determination can be stayed by request for hearing before Nasdaq Hearings Panel.
- No assurance of compliance; risk of delisting if not met.

## SEC filing metadata
- accession: 0001493152-23-039525
- form_type: 8-K
- ticker: RNXT
- cik: 0001574094
- company_name: RenovoRx, Inc.
- filed_at: 2023-11-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1574094/000149315223039525/0001493152-23-039525-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1574094/000149315223039525/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-039525
- JSON: https://secwatch.observer/filing/0001493152-23-039525.json
- Plain text: https://secwatch.observer/filing/0001493152-23-039525.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.